PharmaCyte Biotech (PMCB) Prepaid Assets (2011 - 2026)
PharmaCyte Biotech (PMCB) recorded Prepaid Assets of $32,004 in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 86.6% from $238,180 a year earlier and down 67.0% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Prepaid Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech reported Prepaid Assets of $96,879, down 56.7% from FY2025.
- Annual Prepaid Assets has a five-year compound annual growth rate of 5.8% (FY2021 to FY2026).
- Across earlier fiscal years, Prepaid Assets came in at $223,759 in FY2025 (-13.9%), $259,800 in FY2024 (+141.3%), $107,681 in FY2023 (+14.3%) and $94,172 in FY2022 (+28.8%).
- The fiscal Q1 2027 figure is the lowest quarterly Prepaid Assets since fiscal Q1 2023.
- On a year-over-year basis, Prepaid Assets has declined for three consecutive quarters, with an average decline of 19.7% over the last eight quarters.
- Peak year-over-year performance for Prepaid Assets in the last five years was growth of 317.4% in fiscal Q3 2022, against a decline of 94.9% in fiscal Q1 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $96,879 (Q4 2026), $158,664 (Q3 2026) and $503,147 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 32,004.00 |
| Apr 30, 2026 | 96,879.00 |
| Jan 31, 2026 | 158,664.00 |
| Oct 31, 2025 | 503,147.00 |
| Jul 31, 2025 | 238,180.00 |
| Apr 30, 2025 | 223,759.00 |
| Jan 31, 2025 | 207,362.00 |
| Oct 31, 2024 | 493,213.00 |
| Jul 31, 2024 | 240,227.00 |
| Apr 30, 2024 | 259,800.00 |
| Jan 31, 2024 | 297,762.00 |
| Oct 31, 2023 | 323,189.00 |
| Jul 31, 2023 | 88,650.00 |
| Apr 30, 2023 | 107,681.00 |
| Jan 31, 2023 | 181,008.00 |
| Oct 31, 2022 | 256,808.00 |
| Jul 31, 2022 | 28,148.00 |
| Apr 30, 2022 | 94,172.00 |
| Jan 31, 2022 | 174,101.00 |
| Oct 31, 2021 | 241,799.00 |
API Access
PharmaCyte Biotech Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();